Cvs Health (CVS) Short term Debt (2009 - 2026)

Cvs Health's Short term Debt history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• Quarterly Short term Debt rose 104.92% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 104.92% YoY) and the FY2025 annual result came in at $4.1 billion, up 91.98% from the prior year.
• Short term Debt was $2.6 billion for Q1 2026 at Cvs Health, down from $4.1 billion in the prior quarter.
• Across five years, Short term Debt topped out at $4.9 billion in Q3 2024 and bottomed at $1.0 billion in Q2 2023.
• A 5-year average of $2.9 billion and a median of $2.9 billion in 2023 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2022 — Short term Debt soared 6598.33% — and 2023, when it plunged 75.12%.
• Cvs Health's Short term Debt stood at $1.4 billion in 2022, then soared by 103.37% to $2.8 billion in 2023, then decreased by 23.56% to $2.1 billion in 2024, then jumped by 91.98% to $4.1 billion in 2025, then tumbled by 36.58% to $2.6 billion in 2026.
• Business Quant data shows CVS's Short term Debt at $2.6 billion in Q1 2026, $4.1 billion in Q4 2025, and $4.1 billion in Q3 2025.